Atlas Trials

Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Clinical trial NCT00112710 · UNKNOWN

Trial details

NCT number
NCT00112710
Sponsor
University Hospital Birmingham
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Cancer
Start date
2005-03-01
Enrollment
1350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.